Anna Leland

Associations between methodological quality and representation in clinical trials of systemic lupus erythematosus therapies

Background Randomized clinical trials support drug development and uptake of new therapies for systemic lupus erythematosus (SLE). However, challenges to conducting high-quality clinical trials have been noted, including underrepresentation of minoritized populations. Currently,...